Evidence map›Paper›PMID 42124778›Full record

ArticleCureus2026

Clinical Performance of the Loop-Mediated Isothermal Amplification Method Compared With Reverse Transcriptase Polymerase Chain Reaction for COVID-19 Diagnosis in Indonesia and the Philippines.

Ryo Mizushima, Ivet M Suriapranata, Nelson Geraldino, Tri S Kurniasih, Febi Andriani, Cucunawangsih, Ratna S Wijaya, Nata P Lugito, Michele Hernandez-Diwa, Mark A Ang and 15 more

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Ryo MizushimaDisease Control and Prevention Center, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, JPN.
Ivet M SuriapranataDivision of Molecular Epidemiology, Mochtar Riady Institute for Nanotechnology, Universitas Pelita Harapan, Jakarta, IDN.
Nelson GeraldinoDepartment of Laboratories, Philippine General Hospital, University of the Philippines, Manila, PHL.
Tri S KurniasihDivision of Molecular Epidemiology, Mochtar Riady Institute for Nanotechnology, Universitas Pelita Harapan, Jakarta, IDN.
Febi AndrianiDivision of Molecular Epidemiology, Mochtar Riady Institute for Nanotechnology, Universitas Pelita Harapan, Jakarta, IDN.
CucunawangsihDepartment of Microbiology, Faculty of Medicine, Mochtar Riady Institute for Nanotechnology, Universitas Pelita Harapan, Jakarta, IDN.
Ratna S WijayaDepartment of Microbiology, Faculty of Medicine, Mochtar Riady Institute for Nanotechnology, Universitas Pelita Harapan, Jakarta, IDN.
Nata P LugitoDepartment of Internal Medicine, Faculty of Medicine, Mochtar Riady Institute for Nanotechnology, Universitas Pelita Harapan, Jakarta, IDN.
Michele Hernandez-DiwaDepartment of Pathology, Philippine General Hospital, University of the Philippines, Manila, PHL.
Mark A AngDepartment of Pathology, Philippine General Hospital, University of the Philippines, Manila, PHL.
Gabriel M OzoaDepartment of Laboratories, Philippine General Hospital, University of the Philippines, Manila, PHL.
Timothy Carl F UyDepartment of Laboratories, Philippine General Hospital, University of the Philippines, Manila, PHL.
Scarlett M TabunarDepartment of Emergency Medicine, Philippine General Hospital, University of the Philippines, Manila, PHL.
Maria J GermarDepartment of Obstetrics and Gynecology, Philippine General Hospital, University of the Philippines, Manila, PHL.
Maria T Urbiztondo-BenedictoDepartment of Radiology, Philippine General Hospital, University of the Philippines, Manila, PHL.
Sho SaitoDisease Control and Prevention Center, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, JPN.
Kei YamamotoDisease Control and Prevention Center, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, JPN.
Masahiko SakaguchiDepartment of Information and Communication Engineering, Osaka Electro-Communication University, Osaka, JPN.
Norimitsu HosakaDivision of Research and Development, Biochemical Research Laboratory II, Eiken Chemical Co. Ltd., Tokyo, JPN.
Shota KoyanoDivision of Research and Development, Biochemical Research Laboratory II, Eiken Chemical Co. Ltd., Tokyo, JPN.
Marlinang D SiburianDepartment of International Trials, Center for Clinical Sciences, Japan Institute for Health Security, Tokyo, JPN.
Maria R Umano-UrbiztondoDepartment of International Trials, Center for Clinical Sciences, Japan Institute for Health Security, Tokyo, JPN.
Takashi KobayashiDepartment of International Trials, Center for Clinical Sciences, Japan Institute for Health Security, Tokyo, JPN.
Tetsuo MiuraDepartment of International Trials, Center for Clinical Sciences, Japan Institute for Health Security, Tokyo, JPN.
Norio OhmagariDisease Control and Prevention Center, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Real-time reverse transcriptase polymerase chain reaction (RT-PCR) is considered the gold standard for the diagnosis of coronavirus disease 2019 (COVID-19); however, this method is expensive, time-consuming, and requires skilled personnel. Therefore, this study aimed to evaluate the clinical performance of loop-mediated isothermal amplification (LAMP), a simpler test method. A multinational prospective clinical performance study was conducted in Indonesia and the Philippines, comparing the LAMP method to RT-PCR for the diagnosis of COVID-19. In total, 256 subjects with COVID-19 symptoms underwent RT-PCR testing, of whom 130 and 126 were positive and negative, respectively. In Indonesia (n = 180), 115 (63.9%) tested positive by RT-PCR and 65 (36.1%) tested negative; in the Philippines (n = 76), 15 subjects (19.7%) tested positive by RT-PCR and 61 (80.3%) tested negative. The LAMP and RT-PCR results were concordant in 243/256 subjects (94.9%; 95% confidence interval, 91.5-97.3) (92.8% in Indonesia, 100% in the Philippines). Among 130 RT-PCR-positive subjects, 117 were also positive by LAMP, yielding a sensitivity of 90%. Of the 126 RT-PCR-negative subjects, 126 were also negative by LAMP, yielding a specificity of 100%. The positive and negative predictive values were 100% and 90.6%, respectively. Our study demonstrated high overall accuracy between the LAMP and RT-PCR methods, suggesting the potential utility of the LAMP method for detecting COVID-19 and highlighting its usefulness in managing cases.

Indexed as

accuracyct valueindonesialoop-mediated isothermal amplificationphilippinessevere acute respiratory syndrome coronavirus 2

Identifiers

PMID42124778
PMCPMC13158633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.